We are live on ! Find out more
CEROW

CERo Therapeutics Warrants
CEROW

Delisted

CEROW was delisted on the 30th of October, 2025.

Back to rankings

40 hedge funds and large institutions have $190K invested in CERo Therapeutics Warrants in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less funds holding

Funds holding: 43 → 40 (-3)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

60% less capital invested

Capital invested by funds: $478K → $190K (-$288K)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
40
Holders Change
-3
Holders Change %
-6.98%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
5
Closed
3
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
-$5K

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$4.43K
2
CS
Clear Street
New York
+$1.6K
3
FTUS
Flow Traders U.S.
New York
+$134
4
HF
HRT Financial
New York
+$9
5
Bank of America
Bank of America
North Carolina
+$6

Top Sellers

Rank Fund Capital Flow
1
BI
Bulldog Investors
New Jersey
-$3.45K
2
SCM
Shaolin Capital Management
Florida
-$2.62K
3
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
-$1.61K
4
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$172
5
RCM
Radcliffe Capital Management
Pennsylvania
-$19
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Segantii Capital Management
Hong Kong
$55K – – –
PC
2
Periscope Capital
Ontario, Canada
$25.6K – – –
HCM
3
Highbridge Capital Management
New York
$10.8K – – –
MI
4
MMCAP International
Cayman Islands
$8.81K – – –
CF
5
Cantor Fitzgerald
New York
$8.54K – – –
PAMP
6
Polar Asset Management Partners
Ontario, Canada
$8.25K – – –
SCM
7
Saba Capital Management
New York
$8.14K – – –
LA
8
Linden Advisors
New York
$6.88K – – –
SCM
9
Shaolin Capital Management
Florida
$6.84K -$2.62K -83,999 -22%
AA
10
AQR Arbitrage
Connecticut
$5.8K – – –
CCM
11
Context Capital Management
California
$5.5K – – –
CAC
12
Cowen and Company
New York
$4.7K +$4.43K +142,090 +245%
ACM
13
Atalaya Capital Management
New York
$4.5K – – –
RCM
14
Radcliffe Capital Management
Pennsylvania
$4.11K -$19 -620 -0.4%
QGA
15
Q Global Advisors
Texas
$4K – – –
CS
16
Clear Street
New York
$3.31K +$1.6K +51,355 +57%
NAM
17
Nexpoint Asset Management
Texas
$2.56K – – –
WAM
18
Wolverine Asset Management
Illinois
$2.06K – – –
WCMNY
19
Westchester Capital Management (New York)
New York
$1.88K – – –
KL
20
KIM LLC
Kansas
$1.38K – – –
YCM
21
Yakira Capital Management
Connecticut
$1.38K – – –
TCM
22
Tenor Capital Management
New York
$1.18K – – –
CH
23
CVI Holdings
Delaware
$1.03K -$14 -433 -1%
PMAM
24
Picton Mahoney Asset Management
Ontario, Canada
$1K – – –
FTUS
25
Flow Traders U.S.
New York
$1K +$134 +4,301 +18%
1
2

CEROW Hedge Fund Activity: Q4 2023 in Review

40 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q4 2023, worth a combined $190K — down 60% from $478K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CEROW and 1 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 4 added.

The largest buyer was Cowen and Company, adding an estimated $4.43K. The largest seller was Bulldog Investors, exiting entirely with an estimated $3.45K sold.

  • 40 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q4 2023, down from 43 in Q3 2023.
  • Funds reported $190K of CERo Therapeutics Warrants stock for Q4 2023, down 60% quarter-over-quarter.
  • 1 fund opened new CERo Therapeutics Warrants positions in Q4 2023 and 3 closed out, a net change of -2 holders.
  • The largest CERo Therapeutics Warrants buyer in Q4 2023 was Cowen and Company, an estimated $4.43K added.
  • The largest CERo Therapeutics Warrants seller in Q4 2023 was Bulldog Investors, an estimated $3.45K sold.

Based on aggregated 13F filings for Q4 2023.